[go: up one dir, main page]

TN2010000338A1 - Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant - Google Patents

Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant

Info

Publication number
TN2010000338A1
TN2010000338A1 TNP2010000338A TN2010000338A TN2010000338A1 TN 2010000338 A1 TN2010000338 A1 TN 2010000338A1 TN P2010000338 A TNP2010000338 A TN P2010000338A TN 2010000338 A TN2010000338 A TN 2010000338A TN 2010000338 A1 TN2010000338 A1 TN 2010000338A1
Authority
TN
Tunisia
Prior art keywords
rpe
optionally
vaccine
ribosomal protein
protein extract
Prior art date
Application number
TNP2010000338A
Other languages
French (fr)
Inventor
Manuel Soto Alvarez
Daniel Ruiz Abanades
Carlos Alonso Bedate
Original Assignee
Leti S L Unipersonal Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/050334 external-priority patent/WO2009090175A1/en
Application filed by Leti S L Unipersonal Lab filed Critical Leti S L Unipersonal Lab
Publication of TN2010000338A1 publication Critical patent/TN2010000338A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to composition comprising a RPE and optionally a Th1-promoting adjuvant for the preparation of a medicamet for the treatment or prevention of a parasitic disease and to its use.
TNP2010000338A 2009-01-14 2010-07-19 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant TN2010000338A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/050334 WO2009090175A1 (en) 2008-01-18 2009-01-14 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant

Publications (1)

Publication Number Publication Date
TN2010000338A1 true TN2010000338A1 (en) 2011-12-29

Family

ID=55024468

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000338A TN2010000338A1 (en) 2009-01-14 2010-07-19 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant

Country Status (1)

Country Link
TN (1) TN2010000338A1 (en)

Similar Documents

Publication Publication Date Title
IN2012DN02736A (en)
PH12014501836A1 (en) Novel adjuvant compositions
MX347471B (en) Vaccines comprising cholesterol and cpg as sole adjuvant - carrier molecules.
SG178954A1 (en) Immunogenic compositions including tlr activity modulators
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
WO2007120673A3 (en) Immunogenic wt-1 peptides and methods of use thereof
MX364200B (en) Novel compositions and methods for the treatment of immune related diseases.
UA103930C2 (en) Normal;heading 1;heading 2;heading 3;COMPOUNDS AND COMPOSITION FOR THE TREATMENT OF PARASITIC DISEASES
SG179082A1 (en) Method for the preparation of an influenza virus
WO2009135199A3 (en) Vaccine compositions and methods
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
EA201171001A1 (en) HERBAL PEPTIDES FOR VACCINE
MY172788A (en) Influenza vaccines
TN2012000217A1 (en) The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease
WO2014100857A8 (en) Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
WO2011106705A3 (en) Dna-protein vaccination protocols
BRPI1008721A2 (en) methods for therapeutic or prophylactic treatment of hiv, prophylactic method, therapeutic composition or preparation, combination of therapeutic vaccine, therapeutic method implantation kit
TN2010000338A1 (en) Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
MY158116A (en) Combination vaccine against streptococcus
MX361456B (en) The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease.
WO2007028985A3 (en) Adjuvanted vaccine
WO2013093629A3 (en) Modular vaccines, methods and compositions related thereto
WO2007147518A3 (en) Use of ppd for the adjuvantation of a nucleic acid vaccine
UA104138C2 (en) Novel adjuvant compositions
TH158461A (en) Compounds and constituents as TLR modifiers